Effects of Schedule I drug laws on neuroscience research and treatment innovation
- PMID: 23756634
- DOI: 10.1038/nrn3530
Effects of Schedule I drug laws on neuroscience research and treatment innovation
Abstract
Many psychoactive drugs are used recreationally, particularly by young people. This use and its perceived dangers have led to many different classes of drugs being banned under national laws and international conventions. Indeed, the possession of cannabis, 3,4-methylenedioxy-N-methylamphetamine (MDMA; also known as ecstasy) and psychedelics is stringently regulated. An important and unfortunate outcome of the controls placed on these and other psychoactive drugs is that they make research into their mechanisms of action and potential therapeutic uses - for example, in depression and post-traumatic stress disorder - difficult and in many cases almost impossible.
Comment in
-
Controlled substances and innovation of biomedicine: a preclinical perspective.Nat Rev Neurosci. 2013 Dec;14(12):877. doi: 10.1038/nrn3530-c1. Epub 2013 Oct 23. Nat Rev Neurosci. 2013. PMID: 24149185 No abstract available.
-
New victims of current drug laws.Nat Rev Neurosci. 2013 Dec;14(12):877. doi: 10.1038/nrn3530-c2. Epub 2013 Oct 23. Nat Rev Neurosci. 2013. PMID: 24149187 No abstract available.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources